ICYMI, this week we had stories about holistic treatment for atopic dermatitis management, a recap of the 2022 Revolutionizing Atopic Dermatitis Conference, unmet needs in acne management, and more.
The Revolutionizing Atopic Dermatitis Conference takes place on December 11th, 2022.
Raj Chovatiya, MD, PhD, gives a preview of his discussions on topical formulations of atopic dermatitis and advancing therapeutic expectations at this weekend’s RAD conference.
A poster presentation from the 2022 RAD Conference analyzed manifestations of atopic dermatitis across racial groups.
A 2022 RAD Conference poster presentation explored how to better support caregivers of children with atopic dermatitis.
A 2022 RAD Conference poster presentation explores the efficacy of the therapy for the treatment or prevention of AD.
At the 2022 RAD Virtual Conference, a Harvard University psychologist discusses ways that practitioners can help identify and treat children with adverse mental health outcomes as a result of atopic dermatitis.
A 2022 RAD Conference abstract presentation showed the epidemiology of type 2 associated conditions included in patients with AD.
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss study limitations regarding health records in generalized pustular psoriasis and how the number of flares could be underestimated.
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
At the 2022 RAD virtual conference, a dermatologist examines treatment options for AD in various racial and ethnic groups.
Jonathan Silverberg, MD, PhD, MPHS, gives an overview of topical therapies for atopic dermatitis at the 2022 virtual RAD conference.
Hilary Baldwin, M.D., comments on the impact of the recent approval of clascoterone cream 1% in the topical acne armamentarium of patients suffering from acne.
Dr Hilary Baldwin discusses her treatment considerations and approach in the management of patients with mild to moderate acne, highlighting the benefit of combination therapy.
An expert in acne management shares her insight on the current needs and the role of consensus guidelines in the management of patients suffering from acne.
Hilary Baldwin, M.D., shares her hopes for the future of acne treatment and provides her practice pearls from a panel discussion surrounding the management of patients suffering from acne.
At the RAD 2022 Conference, Steve Xu, MD, MSc, explains how a wearable sensor can better track the progression of atopic dermatitis while a patient is sleeping.
In this month's Cosmetic Condundrums columns, Zoe Diana Draelos, MD, discussed growth factors for anti-aging.
Raj Chovatiya, MD, PhD, and Neal Bhatia, MD, share their thoughts on the clinical implications of the rapid expansion of the atopic dermatitis treatment armamentarium.
Drs Raj Chovatiya and Neal Bhatia highlight the biological targets of current and emerging treatments for the management of atopic dermatitis and discuss the importance of safety and long-term data.
At the RAD 2022 Conference, Keri Kelley, Senior Outreach and Community Manager at Global Parents for Eczema Research discussed a program aimed at providing support for eczema caregivers.
Experts in dermatology discuss the use of oral and topical JAK inhibitors in clinical practice and their reflection of overarching treatment guidelines and indications.
Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.
Drs Raj Chovatiya and Neal Bhatia summarize their final thoughts on the available treatment options for the management of atopic dermatitis.
Nada Elbuluk, MD, and David Rosmarin, MD, share their thoughts on future treatments in the pipeline for vitiligo.
Nada Elbuluk, MD, and David Rosmarin, MD, provide advice to physicians on the management of vitiligo.
Hyaluronic acid is the superhero ingredient of this new skin care line.
Choosing an investment adviser can be an extremely important decision for the long-term financial security of any clinician.
In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.
The PharmaJet Stratis Needle-free Injection System’s vaccine could help prevent a rare but aggressive form of skin cancer.
Catch up on coverage from the 2022 Revolutionizing Atopic Dermatitis Conference.
Linda Stein Gold, MD, and Jennifer Soung, MD, provide an overview of the different, evidence-based topical strategies for treating plaque psoriasis.
Jennifer Soung, MD, provides an overview of the phase III trials, DERMIS-1/DERMIS-2, in which roflumilast was used to treat plaque psoriasis.
A biologic from Germany offers a new treatment option for a number of dermatologic conditions.
Truncal acne, or back acne, is a common skin condition of the pilosebaceous unit, with a global lifetime prevalence of 70% to 85%.
Vitiligo can have a profound effect on mental health and quality of life.
Patients are finding relief in alternative therapy for the chronic skin disease.
Whether occurring in the adult or pediatric population, the diagnosis of blastic plasmacytoid dendritic cell neoplasm is challenging to make and carries a poor prognosis.
Phototherapy can serve an important role in the therapeutic armamentarium of vitiligo as it is safe, cost-effective, and can treat patients with large areas of disease.